Validation and structural characterization of the LEDGF/p75-MLL interface as a new target for the treatment of MLL-dependent leukemia
about
Intrinsic protein disorder in histone lysine methylation.Multiple cellular proteins interact with LEDGF/p75 through a conserved unstructured consensus motifTranscription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients.Epigenetics in T-cell acute lymphoblastic leukemia.MLL leukemia and future treatment strategies.TALEN gene editing takes aim on HIV.Targeting the stress oncoprotein LEDGF/p75 to sensitize chemoresistant prostate cancer cells to taxanes.LEDGF/p75 is dispensable for hematopoiesis but essential for MLL-rearranged leukemogenesis.Molecular processes involved in B cell acute lymphoblastic leukaemia.Cellular and molecular mechanisms of HIV-1 integration targeting.Complementary activities of DOT1L and Menin inhibitors in MLL-rearranged leukemia.Cloning, purification and structure determination of the HIV integrase-binding domain of lens epithelium-derived growth factor.
P2860
Q27335553-12559C28-97DA-43F3-A38E-4188A8D4BE50Q27701733-28B1F03F-6C5B-41CF-AE25-53A8055DD234Q37116260-D61B2B33-4501-40B8-9EC1-73A8AA3D4865Q38289023-542FCC6E-BBAF-41F8-8945-05679B899EEBQ38367735-7463C7E1-264B-418A-9F3A-9BF67E521EA7Q38832507-A349AC86-6E49-4AA3-9C98-EE0EF2D8E529Q41829738-930E0C24-E625-43C7-AE96-84D7675AAEEBQ45873757-4FAB00E0-C330-4A4B-B403-80CA5CADC3BCQ48218289-0523BDC7-F67F-4DC3-BF5A-51831DA6376FQ50126703-A09EC513-EF7B-476A-853F-CFFAB1F0D8C6Q50477441-4F10CBEC-D536-4D40-B6FF-4797A0127D24Q52370158-2B2397F9-AFA7-441D-B4AD-384BFD0768EC
P2860
Validation and structural characterization of the LEDGF/p75-MLL interface as a new target for the treatment of MLL-dependent leukemia
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Validation and structural char ...... ment of MLL-dependent leukemia
@ast
Validation and structural char ...... ment of MLL-dependent leukemia
@en
Validation and structural char ...... ment of MLL-dependent leukemia
@nl
type
label
Validation and structural char ...... ment of MLL-dependent leukemia
@ast
Validation and structural char ...... ment of MLL-dependent leukemia
@en
Validation and structural char ...... ment of MLL-dependent leukemia
@nl
prefLabel
Validation and structural char ...... ment of MLL-dependent leukemia
@ast
Validation and structural char ...... ment of MLL-dependent leukemia
@en
Validation and structural char ...... ment of MLL-dependent leukemia
@nl
P2093
P50
P3181
P1433
P1476
Validation and structural char ...... ment of MLL-dependent leukemia
@en
P2093
Hélène Méreau
Jan De Rijck
Juerg Schwaller
Sara El Ashkar
P304
P3181
P356
10.1158/0008-5472.CAN-13-3602
P407
P577
2014-07-31T00:00:00Z